MC10, a Lexington, Mass.–based wearable sensor developer, raised $9.2 million in an offering of promissory notes and warrants convertible into preferred stock to 18 investors, according to regulatory filing.
The flexible electronics company still needs to raise $767,038 to reach the offering’s $10 million total.
MC10’s BioStamp wearable sensors collect and transmit biometric data, allowing researchers to share data with each other across research sites. The company’s devices can be used simultaneously on multiple body locations.
In April last year, MC10 inked a limited exclusive distribution partnership with Marubun Corp. to distribute its products in Japan. Marubun has also joined the company’s strategic equity investors.
MC10 also released its L’Oreal partnered MyUV Patch in 2016. The 1-inch transparent adhesive contains photosensitive dyes that factor in skin tone and change colors when exposed to UV rays to indicate levels of sun exposure.
Users can take pictures of the patch and upload them to a custom mobile app that analyzes the dye squares to determine their level of UV exposure. The app is available on Apple (NSDQ:AAPL) iOS and Google (NSDQ:GOOG) Android devices.
See the best minds in medtech live at DeviceTalks Boston on Oct. 2.
